Monoclonal antibodies and the recombinant proteins
Post# of 144499
Posted On: 01/15/2016 1:55:43 PM
Monoclonal antibodies and the recombinant proteins ~ Check this out!
Quote:
$IMNP IMMUNE has licensed the GS system from Lonza for the manufacturing process of Bertilimumab, planning several GMP batches including one in 2012 in anticipation of phase II clinical trials. Headquartered in Basel, Switzerland, Lonza's approach is to provide broad development and manufacturing package to their customers. Publically traded on the Zurich Stock Exchange, Lonza is one of the world leaders in contract manufacturing of monoclonal antibodies and recombinant proteins using mammalian cell culture. This program was established over 25 years ago, just one of many paths the company has followed since its founding in 1897. Please visit Lonza.com for more information on the company.
Quote:
$IMNP IMMUNE has licensed the GS system from Lonza for the manufacturing process of Bertilimumab, planning several GMP batches including one in 2012 in anticipation of phase II clinical trials. Headquartered in Basel, Switzerland, Lonza's approach is to provide broad development and manufacturing package to their customers. Publically traded on the Zurich Stock Exchange, Lonza is one of the world leaders in contract manufacturing of monoclonal antibodies and recombinant proteins using mammalian cell culture. This program was established over 25 years ago, just one of many paths the company has followed since its founding in 1897. Please visit Lonza.com for more information on the company.
(0)
(0)Scroll down for more posts ▼